HOW SHOULD WE SUPPORT PATIENTS WITH PRIMARY BRAIN TUMOURS WHO ELECT TO TAKE CANNABINOIDS?

INTRODUCTION: Primary brain tumours account for 3% of new cancer cases (2015) but account disproportionately in terms of mortality and morbidity. With radical treatment prognosis is variable; ranging from 80% survival for 5 years or more for benign meningiomas to a dismal 5% for Glioblastoma multifo...

詳細記述

保存先:
書誌詳細
出版年:Neuro Oncol
主要な著者: La, Jessica, Hurwitz, Victoria, Mullens, Laura, Brazil, Lucy, Gullan, Richard, Bhangoo, Ranj, Vergani, Francesco, Beaney, Ronald, Ashkan, Keyoumars, Rooprai, Bali, Swampillai, Angela
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2018
主題:
Abstracts
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6168826/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy129.028
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料